AI can support documentation, triage, education, measurement, and pattern recognition in physiotherapy. Its value depends on validated performance, representative data, transparent use, and clinician review. These systems can assist clinical judgment, but the physiotherapist remains accountable for the decision and for recognizing confident errors or bias.
Extended reality includes virtual, augmented, and mixed reality. It can create simulated practice or layer guidance over the real environment to increase repetition, feedback, and engagement. Gains still need to transfer into daily life, and systems require screening for cybersickness, fatigue, falls risk, accessibility, and whether the digital cue solves a clear motor-learning problem.
Neural interfaces can read motor intent, while neuromodulation uses electrical or magnetic stimulation to change nervous-system activity. In selected neurological conditions, these tools may support movement practice when paired with intensive, task-specific rehabilitation. Physiotherapists may help select candidates, design the training task, monitor safety, and test whether gains transfer into meaningful function; most applications remain specialized and the evidence is still developing.
Rehabilitation robots and wearable exoskeletons can deliver intensive, repeatable movement practice and physical assistance. They are most useful when a therapist actively adjusts the task, assistance, feedback, and progression. More repetitions do not automatically produce meaningful recovery, so outcomes must include real function, participation, safety, and the patient’s experience.
3D printing can create individualized orthoses, prosthetic components, splints, and rehabilitation tools from digital scans and designs. The opportunity is faster iteration and better fit, not printing for its own sake. Safe use requires material and device controls, documented design changes, fit testing, follow-up, and a clear regulatory pathway.
Genomic information may eventually help identify biological differences that influence recovery, but it is not ready to prescribe routine physiotherapy. Personalization is already possible through patient goals, context, baseline measures, and response to treatment. Consumer genetic reports should not determine rehabilitation without clinical validation, qualified interpretation, privacy protection, and clear evidence of benefit.
Predictive analytics can help estimate risk, recovery, and service needs, but reliable models begin with trustworthy clinical data. Physiotherapy services need shared definitions, practical outcome measures, representative populations, and clear governance. A prediction is useful only when it is well calibrated locally and leads to a better decision than ordinary assessment.
Wearables and connected devices can reveal activity, gait, exercise, sleep, or symptoms between visits. Collecting a signal also creates a duty to define who reviews it, when they act, and what happens after hours. Device accuracy, patient context, privacy, workload, and a clear stop rule matter as much as the data itself.
Virtual care is a service model, not simply a video appointment. It combines online, in-person, telephone, and between-visit support according to the patient’s goals, risks, location, technology, and preferences. A strong pathway defines what can be assessed remotely, when care changes mode, how privacy and emergencies are managed, and who carries the cost.
Regenerative therapies include different products and claims, from platelet-rich plasma to cell and tissue-engineering approaches. Physiotherapists should separate symptom relief, structural change, and functional recovery; verify the exact product and local authorization; and build a measured loading plan. Biology may change healing conditions, but rehabilitation still rebuilds capacity and participation.
These overviews introduce the model’s areas of inquiry. Evidence, appropriate uses, and limitations vary within each domain.